Bortezomib-pinanediol (CAS No: 205393-22-2) is a key pharmaceutical intermediate used in the synthesis of APIs Bortezomib. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: Bortezomib Pinanediol Ester, N-[(2S)-1-[[(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]butyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide
CAS No: 205393-22-2
PubChem CID: 16221476
Mol Formula: C29H39BN4O4
Mol Weight: 518.5 g/mol
Used in API: Bortezomib
IUPAC Name: N-[(2S)-1-[[(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]butyl]amino]-1-oxo-3-phenylpropan -Show More
API Intermediate Description: Bortezomib-pinanediol is a boronic ester derivative of bortezomib, in which the boronic acid moiety is protected as a pinanediol ester. It is commonly used as a stable synthetic intermediate in the preparation and handling of bortezomib, an anticancer proteasome inhibitor.
